Saudi Press

Saudi Arabia and the world
Saturday, Feb 22, 2025

Stage 3 Lung Cancer Immunotherapy | Immunotherapy Drugs for Lung Cancer

Immunotherapy is a new form of cancer treatment, helping your body harness the power of your own immune system to manage stage 3 lung cancer.

Lung cancer is the most common cancer worldwide, causing 25% of all cancer deaths. That’s why researchers are working diligently to develop new treatment strategies to provide better outcomes for people living with advanced lung cancer.

If you’ve been diagnosed with stage 3 lung cancer, you likely have questions about your treatment options. Fortunately, there are many therapies your doctor may recommend to manage your condition. One of the newest methods of dealing with advanced lung cancers is immunotherapy, which harnesses the power of your body’s immune system to fight and kill cancer cells.

While immunotherapy shows promise as an effective treatment option for many people with stage 3 lung cancer, it’s not an appropriate treatment option for everyone. If you’re interested in immunotherapy, it’s best to ask your doctor if this treatment could be right for you.


Managing Stage 3 Lung Cancer


Lung cancer is categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC makes up 80 to 85% of all diagnosed lung cancers. Regardless of the type, after a lung cancer diagnosis is made, doctors work quickly to determine the stage of the cancer—that is, whether or not the cancer has spread outside the lungs and, if so, how far.

People living with stage 3 lung cancer have tumors growing inside lung tissue as well as cancer that’s spread beyond the lungs. In general, stage 3 lung cancer affects the lungs and lymph nodes in the chest, including those surrounding the lungs and airways near the collarbone. While stage 3 lung cancer may affect lymph nodes on either side of the chest, it has not yet spread to distant organs or tissues.

For many people, advanced lung cancer is treated with a combination of therapies. Your treatment course depends on how far your cancer has spread and your overall health. Many people benefit from more traditional cancer therapies, including chemotherapy and radiation therapy. But while these are good options, they are not as precise as newer treatments like immunotherapy. Also, you may want to avoid some of the side effects of these classic treatment options. That’s where immunotherapy comes in.


Immunotherapy Explained

Immunotherapy is a relatively new form of treatment that uses your body’s own immune system to kill cancer cells. Immunotherapy drugs for lung cancer help your body better recognize and destroy cancer cells. But to understand how immunotherapy works, it’s important to first understand how your immune system works.

Your immune system sends fighter cells to attack invaders like bacteria and viruses. Typically, it knows to leave normal, healthy cells alone. This is accomplished by certain structures on immune system cells, called checkpoints, that get turned on or off depending on whether a cell is normal or not. Some cancer cells have the ability to fool your immune system to disregard the presence of abnormal, malignant cells.

Immunotherapy drugs target immune system cell checkpoints to encourage your body to attack harmful cancer cells. By stimulating these checkpoints, immunotherapy drugs effectively take the breaks off your immune system, releasing it to destroy cancer cells.

If immunotherapy is right for you, you’ll receive your medications as an intravenous (IV) infusion every two to three weeks. But keep in mind, like all cancer treatments, immunotherapy does pose the risk of certain side effects. You may experience fatigue, nausea, diarrhea, cough, skin rashes, or joint pain. In rare cases, immunotherapy drugs cause the immune system to attack other parts of your body, such as your liver or kidneys. If this occurs, your treatment may need to stop.

Immunotherapy is a newer form of treatment for stage 3 lung cancer, but it’s showing promise as an effective solution for dealing with this disease. While it isn’t right for everyone, immunotherapy may allow you to use your own body to help fight your cancer. If you’re interested in immunotherapy as a treatment option, ask your doctor whether this therapy could be right for you.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Saudi Arabia and the United States Strengthen Ties Amid Global Developments
Saudi Arabia Hosts Global Conference to Promote Islamic Unity
The Impact of Artificial Intelligence on Education and Child Development
Saudi Arabia Announces Competition for Best Founding Day Outfits
Saudi-EU Food Security Officials Hold Talks to Strengthen Collaboration
Putin Expresses Gratitude to Saudi Crown Prince for Hosting US-Russia Talks
UK and Saudi Arabia Enhance Collaboration in Innovation and Technology
Denmark's Embassy in Riyadh Showcases Danish Cuisine with Saudi Influence
Saudi Artist Salman Al-Amir Unveils 'Tafawut' Exhibition in Riyadh
Saudi Arabia Offers Condolences to Kuwait Following Military Exercise Fatalities
Saudi Ministry of Islamic Affairs Completes Ramadan Preparations in Madinah
Etidal Secretary-General Hosts UN Counter-Terrorism Director in Riyadh
ADNOC Drilling Targets Over $1 Billion in Investments for 2025 Amid Gulf Expansion Plans
Derayah Financial Achieves Remarkable Growth in Saudi Brokerage and Asset Management
Saudi Arabia Shortlists 30 Firms for Mining Licenses in Eastern Province and Tabuk
Saudi Foreign Minister Engages Counterparts at G20 Meeting in Johannesburg
Oil Prices Decline Amid Rising US Inventories
Saudi Arabia's NDMC Plans Green Bond Issuance by 2025
Moody’s Affirms Egypt’s Caa1 Rating Amid Positive Economic Outlook
Oman and Saudi Arabia Strengthen Economic Ties with New Agreements
Saudi Arabia Investments Propel Expansion of Qurayyah Power Plant
Saudi Capital Market Authority Advances SPACs and Direct Listings
Global Energy Leaders Gather in Riyadh for Symposium on Energy Outlooks
Al-Ahsa Region Sees 500% Growth in Tourism as Saudi Arabia Prioritizes Development
Saudi Arabia Advances Entrepreneurial Ecosystem in Al-Ahsa with New Agreement
King Salman Approves Official Saudi Riyal Symbol
Saudi Credit Card Lending Reaches $8.4 Billion Amid Digital Payment Expansion
King Salman Approves Official Symbol for Saudi Riyal
Putin Thanks Saudi Crown Prince for Facilitating U.S.-Russia Discussions
Saudi Foreign Minister Attends G20 Meeting in Johannesburg
Saudi Arabia Prepares for Nationwide Founding Day Celebrations
Inauguration of Hira Park and Walkway Enhances Jeddah's Urban Landscape
Crown Prince Hosts Leaders for Informal Meeting in Riyadh Amid Gaza Rebuilding Plans
Saudi Official Highlights Achievements and Media's Role in National Transformation
Three Expatriate Women Arrested for Prostitution in Riyadh
Saudi Arabia's Diplomatic Evolution Highlighted at Saudi Media Forum
Healthy Eating and Preparation Essential for Ramadan Fasting
Saudi Arabia and Japan Forge Sustainable Textile Partnership
Advanced Limb Surgery Restores Mobility in Pediatric Cancer Patient
Jeddah Event Explores AI's Role in Boosting Saudi Arabia's SME Sector
UN Representative Highlights AI's Role in Perpetuating Gender Stereotypes
Saudi and Jordanian Leaders Discuss Enhanced Security Cooperation in Amman
Saudi British Society Honors Cultural Bridge-Builders at London Gala
Saudi Media Forum 2025 Explores AI's Role in Modern Journalism
Saudi Arabia's Saqer Al-Moqbel Appointed as WTO General Council President for 2025–2026
Saudi Deputy Ministers Engage in Diplomatic Discussions with U.S. and Dutch Officials in Riyadh
Saudi Arabia to Launch Iftar Program in 61 Countries During Ramadan
Saudi Visitors Expected to Spend £942 Million in UK During 2025
Saudi Arabia Gifts Kaaba's Kiswah to Uzbekistan's Center of Islamic Civilization
Digital Cooperation Organization Concludes Fourth General Assembly with Multiple Agreements
×